Letter from the editor.
作者信息
Ellis Ronald, Riedmann Eva M
机构信息
Senior Vice President R&D and Chief Technology Officer; NasVax, Ltd.; Ness Ziona, Israel.
Acquisitions Editor; Landes Bioscience; Vienna, Austria.
出版信息
Hum Vaccin Immunother. 2014;10(4):813-4. doi: 10.4161/hv.29049. Epub 2014 Apr 1.
Abstract
摘要
相似文献
1
Letter from the editor.编辑来信。
Hum Vaccin Immunother. 2014;10(4):813-4. doi: 10.4161/hv.29049. Epub 2014 Apr 1.
2
Vaccine adjuvants: is the pipeline clogged?疫苗佐剂：研发渠道堵塞了吗？
Immunotherapy. 2012 Jun;4(6):565-7. doi: 10.2217/imt.12.43.
3
Applications of chemokines as adjuvants for vaccine immunotherapy.趋化因子作为疫苗免疫疗法佐剂的应用。
Immunobiology. 2018 Jun-Jul;223(6-7):477-485. doi: 10.1016/j.imbio.2017.12.001. Epub 2017 Dec 8.
4
ISCOMATRIX: a novel adjuvant for use in prophylactic and therapeutic vaccines against infectious diseases.免疫刺激复合物佐剂：一种新型佐剂，可用于预防和治疗传染病的疫苗。
J Med Microbiol. 2012 Jul;61(Pt 7):935-943. doi: 10.1099/jmm.0.040857-0. Epub 2012 Mar 22.
5
Nanomedicine and immunotherapy.纳米医学与免疫疗法。
Expert Rev Vaccines. 2010 Nov;9(11):1245-6. doi: 10.1586/erv.10.128.
6
Letter from the Editor.编辑来信。
Hum Vaccin Immunother. 2018 Jan 2;14(1):1. doi: 10.1080/21645515.2018.1420843.
7
Improving Vaccine and Immunotherapy Design Using Biomaterials.利用生物材料改进疫苗和免疫疗法设计。
Trends Immunol. 2018 Feb;39(2):135-150. doi: 10.1016/j.it.2017.10.002. Epub 2017 Dec 14.
8
Conference scene--active immunotherapeutics forum: meeting highlights.会议现场——主动免疫疗法论坛：会议亮点
Immunotherapy. 2009 Sep;1(5):743-8. doi: 10.2217/imt.09.52.
9
Why and How Vaccines Work.疫苗为何以及如何发挥作用。
Cell. 2020 Oct 15;183(2):290-295. doi: 10.1016/j.cell.2020.09.040.
10
New adjuvants for human vaccines.新型人用疫苗佐剂。
Curr Opin Immunol. 2010 Jun;22(3):411-6. doi: 10.1016/j.coi.2010.04.004. Epub 2010 May 11.
Zotero 插件